XXI Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
XXI Wealth's PFE Position: Q3 2026 in Review
XXI Wealth reduced its Pfizer (PFE) stake by 28% in Q3 2026, selling an estimated $198K and leaving 18,708 shares worth $534K. The position accounts for 0.21% of the portfolio, ranked #118.
XXI Wealth first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. The position peaked at $865K in Q1 2026. 2,877 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- XXI Wealth held 18,708 shares of Pfizer worth $534K as of Q3 2026.
- XXI Wealth sold 7,426 Pfizer shares in Q3 2026, an estimated $198K.
- Pfizer made up 0.21% of XXI Wealth's portfolio in Q3 2026, its #118 holding.
- XXI Wealth first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
- XXI Wealth's Pfizer position peaked at $865K in Q1 2026.
- 2,877 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.